MERTK as a novel therapeutic target in head and neck cancer

Although head and neck cancer (HNSCC) is the sixth most common tumor entity worldwide therapy options remain limited leading to 5-year survival rates of only 50 %. MERTK is a promising therapeutic target in several tumor entities, however, its role in HNSCC has not been described yet. The aim of our...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncotarget
Autori principali: von Mässenhausen, Anne, Sanders, Christine, Thewes, Britta, Deng, Mario, Queisser, Angela, Vogel, Wenzel, Kristiansen, Glen, Duensing, Stefan, Schröck, Andreas, Bootz, Friedrich, Brossart, Peter, Kirfel, Jutta, Heasley, Lynn, Brägelmann, Johannes, Perner, Sven
Natura: Artigo
Lingua:Inglês
Pubblicazione: Impact Journals LLC 2016
Soggetti:
Research Paper
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5078043/
https://ncbi.nlm.nih.gov/pubmed/27081701
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.8724
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi